|
Volumn 63, Issue 2, 2011, Pages 129-137
|
A novel single-chain variable fragment antibody against FGF-1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF-1.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CDKN1A PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
FIBROBLAST GROWTH FACTOR 1;
RECOMBINANT PROTEIN;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
TUMOR MARKER;
ANIMAL;
ARTICLE;
BREAST TUMOR;
CELL CYCLE;
CELL PROLIFERATION;
CHEMISTRY;
DRUG EFFECT;
ESCHERICHIA COLI;
FEMALE;
GENE EXPRESSION;
GENETICS;
HUMAN;
HYBRIDOMA;
IMMUNOLOGY;
IMMUNOMODULATION;
METABOLISM;
METHODOLOGY;
MOLECULAR GENETICS;
MOLECULARLY TARGETED THERAPY;
MOUSE;
NUCLEOTIDE SEQUENCE;
PATHOLOGY;
SECRETION;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
UPREGULATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BASE SEQUENCE;
BREAST NEOPLASMS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
ESCHERICHIA COLI;
FEMALE;
FIBROBLAST GROWTH FACTOR 1;
GENE EXPRESSION;
HUMANS;
HYBRIDOMAS;
IMMUNOMODULATION;
MICE;
MOLECULAR SEQUENCE DATA;
MOLECULAR TARGETED THERAPY;
RECOMBINANT PROTEINS;
SIGNAL TRANSDUCTION;
SINGLE-CHAIN ANTIBODIES;
TUMOR MARKERS, BIOLOGICAL;
UP-REGULATION;
|
EID: 79959511970
PISSN: None
EISSN: 15216551
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|